NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.08
+0.02 (+0.65%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+590.9% upside
Low Target
$14.65
Average Target
$21.28
High Target
$27.46
Current Price
$3.08
Current
$3.08
$3.08
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Scenario Analysis
Bear Case
$14.65
375.6%
Low target
Base Case
$21.28
+590.9%
Avg target
Bull Case
$27.46
+791.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.84
-19.8% from high
52-Week Low
$1.62
+90.1% from low
Target vs 52W High
$21.28
+454.2% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $0.43
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals